Skip to search.
 TSX Up 0.07% TSX Ventures  0.00%
Streaming
Ticker Tape: On

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS

1.59 Down 0.07(4.22%) 4:00PM EDT

Add to Portfolio
Prev Close:1.66
Open:1.63
Bid:1.59 x 300
Ask:1.75 x 1000
1y Target Est:3.13
Beta:2.08
Next Earnings Date: 6-Aug-13BCRX Earnings announcement
Day's Range:1.58 - 1.69
52wk Range:1.08 - 4.95
Volume:844,970
Avg Vol (3m):1,490,220
Market Cap:84.50M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 4.22%84.50M
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.59%11.96B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.46
Quarterly EPS Est (Jun-13) :-0.14
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback